(2024)
Mod5 mediates a molecular trade-off between optimal gene expression and antifungal resistance.
bioRxiv
[Preprint]
Prof. Dr. Gianni Panagiotou
Microbiome Dynamics · Head +49 3641 532-1759 gianni.panagiotou@leibniz-hki.deCurriculum vitae
Main Research Areas
- Medical & Environmental Metagenomics: human, mice, marine, plants;
- Systems Biology: -omics integration, chemical-protein & protein-protein interaction networks;
- Synthetic Biology: genome-scale metabolic modelling, design of probiotics, discovery of postbiotics
Publications
(2024)
Distinct changes in serum metabolites and lipid species in the onset and progression of NAFLD in obese Chinese.
Comput Struct Biotechnol J 23(2024),
791-800.
(2024)
Risk assessment with gene expression markers in sepsis development.
Cell Rep Med 5(9),
101712.
(2024)
In-vitro influence of specific Bacteroidales strains on gut and liver health related to Metabolic dysfunction-associated fatty liver disease.
Probiotics Antimicrob Proteins
[Epub ahead of print]
(2024)
CD56-mediated activation of human natural killer cells is triggered by Aspergillus fumigatus galactosaminogalactan.
PLOS Pathog 20(6),
e1012315.
(2024)
Resistant starch intake facilitates weight loss in humans by reshaping the gut microbiota.
Nat Metab 6(3),
578-597.
(2024)
A global survey of host, aquatic, and soil microbiomes reveals shared abundance and genomic features between bacterial and fungal generalists.
Cell Rep 43(4),
114046.
(2024)
Life goes on: Spatial heterogeneity promotes biodiversity in an urbanized coastal marine ecosystem.
Glob Chang Biol 30(4),
e17248.
(2024)
Controlling substrate- and stereospecificity of condensation domains in nonribosomal peptide synthetases.
ACS Chem Bio 19(3),
599-606.
(2024)
Strain dynamics of contaminating bacteria modulate the yield of ethanol biorefineries.
Nat Commun 15(1),
5323.